Erin Cravez, MD
Hand Surgery · Branford, CTNPI 1851748990
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (45.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Arthrex at 55.4% of the total. Reporting peaked in 2022 at $4,550 and has fallen 92.6% since, to $335 in 2025.
Across 33 payments — averaging $238.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Axogen$3K
- Gotham Surgical Solutions & Devices, Inc.$163
- Bone Support Inc.$131
- Dilon Technologies, Inc.$109
- Endo USA, Inc.$102
- plus $186 from 4 others
What the payments were for
- Travel & lodging$2,87236%
- Food & beverage$1,40918%
- Education$3,60046%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 17 | $4,366 |
| Axogen | 5 | $2,824 |
| Gotham Surgical Solutions & Devices, Inc. | 2 | $163 |
| Bone Support Inc. | 1 | $131 |
| Dilon Technologies, Inc. | 1 | $109 |
| Endo USA, Inc. | 2 | $102 |
| Endo Pharmaceuticals Inc. | 2 | $91 |
| Smith+Nephew | 1 | $57 |
| Polaris Technology Solutions LLC | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVANCE NERVE GRAFT$2,824
- AxoGuard Nerve Connector$2,824
- AxoGuard Nerve Protector$2,824
- CERAMENTBONE VOID FILLER$131
- CERAMENT G$131
- HemoBlast Bellows$109
How this compares
$7,881 in reported general payments places this provider in the 80th percentile of 54 hand surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 38 | $594 |
| Oxycodone Hcl | 38 | $139 |
| Meloxicam | 57 | $64 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $44 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Branford
- Michael RedlerTrumbull$763K
- Richard BernsteinHamden$437K
- Lisa LattanzaNew Haven$156K
- Kenneth DonohueNew Haven$41K
- Paul ProtomastroNorwalk$16K
- Mark VitaleGreenwich$13K
- Erik CarlsonMiddlebury$13K
- Devon BandaGlastonbury$10K
- Douglas WischTorrington$9K
- Ryan NaujoksMiddletown$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.